179 related articles for article (PubMed ID: 24085295)
1. Elucidation of molecular impediments in the α6 subunit for in vitro expression of functional α6β4* nicotinic acetylcholine receptors.
Jensen AB; Hoestgaard-Jensen K; Jensen AA
J Biol Chem; 2013 Nov; 288(47):33708-33721. PubMed ID: 24085295
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological characterisation of α6β4⁎ nicotinic acetylcholine receptors assembled from three chimeric α6/α3 subunits in tsA201 cells.
Jensen AB; Hoestgaard-Jensen K; Jensen AA
Eur J Pharmacol; 2014 Oct; 740():703-13. PubMed ID: 24952132
[TBL] [Abstract][Full Text] [Related]
3. Roles for N-terminal extracellular domains of nicotinic acetylcholine receptor (nAChR) β3 subunits in enhanced functional expression of mouse α6β2β3- and α6β4β3-nAChRs.
Dash B; Li MD; Lukas RJ
J Biol Chem; 2014 Oct; 289(41):28338-51. PubMed ID: 25028511
[TBL] [Abstract][Full Text] [Related]
4. Reporter mutation studies show that nicotinic acetylcholine receptor (nAChR) α5 Subunits and/or variants modulate function of α6*-nAChR.
Dash B; Chang Y; Lukas RJ
J Biol Chem; 2011 Nov; 286(44):37905-37918. PubMed ID: 21873428
[TBL] [Abstract][Full Text] [Related]
5. α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.
Hone AJ; Scadden M; Gajewiak J; Christensen S; Lindstrom J; McIntosh JM
Mol Pharmacol; 2012 Nov; 82(5):972-82. PubMed ID: 22914547
[TBL] [Abstract][Full Text] [Related]
6. Human alpha6 AChR subtypes: subunit composition, assembly, and pharmacological responses.
Kuryatov A; Olale F; Cooper J; Choi C; Lindstrom J
Neuropharmacology; 2000 Oct; 39(13):2570-90. PubMed ID: 11044728
[TBL] [Abstract][Full Text] [Related]
7. Analysis of rare variations reveals roles of amino acid residues in the N-terminal extracellular domain of nicotinic acetylcholine receptor (nAChR) alpha6 subunit in the functional expression of human alpha6*-nAChRs.
Dash B; Li MD
Mol Brain; 2014 May; 7():35. PubMed ID: 24886653
[TBL] [Abstract][Full Text] [Related]
8. "Orphan" alpha6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor.
Gerzanich V; Kuryatov A; Anand R; Lindstrom J
Mol Pharmacol; 1997 Feb; 51(2):320-7. PubMed ID: 9203638
[TBL] [Abstract][Full Text] [Related]
9. Extending the analysis of nicotinic receptor antagonists with the study of alpha6 nicotinic receptor subunit chimeras.
Papke RL; Dwoskin LP; Crooks PA; Zheng G; Zhang Z; McIntosh JM; Stokes C
Neuropharmacology; 2008 Jun; 54(8):1189-200. PubMed ID: 18448138
[TBL] [Abstract][Full Text] [Related]
10. Efficient expression of functional (α6β2)2β3 AChRs in Xenopus oocytes from free subunits using slightly modified α6 subunits.
Ley CK; Kuryatov A; Wang J; Lindstrom JM
PLoS One; 2014; 9(7):e103244. PubMed ID: 25068303
[TBL] [Abstract][Full Text] [Related]
11. α-Conotoxin VnIB from Conus ventricosus is a potent and selective antagonist of α6β4* nicotinic acetylcholine receptors.
van Hout M; Valdes A; Christensen SB; Tran PT; Watkins M; Gajewiak J; Jensen AA; Olivera BM; McIntosh JM
Neuropharmacology; 2019 Oct; 157():107691. PubMed ID: 31255696
[TBL] [Abstract][Full Text] [Related]
12. Expression and functional characterisation of a human chimeric nicotinic receptor with alpha6beta4 properties.
Evans NM; Bose S; Benedetti G; Zwart R; Pearson KH; McPhie GI; Craig PJ; Benton JP; Volsen SG; Sher E; Broad LM
Eur J Pharmacol; 2003 Apr; 466(1-2):31-9. PubMed ID: 12679139
[TBL] [Abstract][Full Text] [Related]
13. Incomplete incorporation of tandem subunits in recombinant neuronal nicotinic receptors.
Groot-Kormelink PJ; Broadbent SD; Boorman JP; Sivilotti LG
J Gen Physiol; 2004 Jun; 123(6):697-708. PubMed ID: 15148328
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinants of α-conotoxin potency for inhibition of human and rat α6β4 nicotinic acetylcholine receptors.
Hone AJ; Talley TT; Bobango J; Huidobro Melo C; Hararah F; Gajewiak J; Christensen S; Harvey PJ; Craik DJ; McIntosh JM
J Biol Chem; 2018 Nov; 293(46):17838-17852. PubMed ID: 30249616
[TBL] [Abstract][Full Text] [Related]
15. Analogs of alpha-conotoxin MII are selective for alpha6-containing nicotinic acetylcholine receptors.
McIntosh JM; Azam L; Staheli S; Dowell C; Lindstrom JM; Kuryatov A; Garrett JE; Marks MJ; Whiteaker P
Mol Pharmacol; 2004 Apr; 65(4):944-52. PubMed ID: 15044624
[TBL] [Abstract][Full Text] [Related]
16. Subtype-specific mechanisms for functional interaction between α6β4* nicotinic acetylcholine receptors and P2X receptors.
Limapichat W; Dougherty DA; Lester HA
Mol Pharmacol; 2014 Sep; 86(3):263-74. PubMed ID: 24966348
[TBL] [Abstract][Full Text] [Related]
17. Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels.
Khiroug SS; Harkness PC; Lamb PW; Sudweeks SN; Khiroug L; Millar NS; Yakel JL
J Physiol; 2002 Apr; 540(Pt 2):425-34. PubMed ID: 11956333
[TBL] [Abstract][Full Text] [Related]
18. Identification of N-terminal extracellular domain determinants in nicotinic acetylcholine receptor (nAChR) α6 subunits that influence effects of wild-type or mutant β3 subunits on function of α6β2*- or α6β4*-nAChR.
Dash B; Bhakta M; Chang Y; Lukas RJ
J Biol Chem; 2011 Nov; 286(44):37976-37989. PubMed ID: 21832048
[TBL] [Abstract][Full Text] [Related]
19. Expression of functional human α6β2β3* acetylcholine receptors in Xenopus laevis oocytes achieved through subunit chimeras and concatamers.
Kuryatov A; Lindstrom J
Mol Pharmacol; 2011 Jan; 79(1):126-40. PubMed ID: 20923852
[TBL] [Abstract][Full Text] [Related]
20. Modulation of gain-of-function α6*-nicotinic acetylcholine receptor by β3 subunits.
Dash B; Lukas RJ
J Biol Chem; 2012 Apr; 287(17):14259-69. PubMed ID: 22315221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
